Impact of 68Ga-PSMA-11 PET/CT on salvage radiotherapy planning in post-prostatectomy patients with early biochemical recurrence

被引:0
|
作者
Calais, J. [1 ]
Czernin, J. [1 ]
Fendler, W. P. [1 ,2 ]
Herrmann, K. [1 ,3 ]
Rauscher, I. [4 ]
Hegemann, N. [2 ]
Poeppel, T. [3 ]
Cao, M. [1 ]
Eiber, M. [1 ,4 ]
Nickols, N. [1 ]
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Ludwig Maximilians Univ Munchen, Munich, Germany
[3] Univ Klinikum Essen, Essen, Germany
[4] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-126
引用
收藏
页码:S168 / S168
页数:1
相关论文
共 50 条
  • [31] Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy
    Usman Bashir
    Alison Tree
    Erik Mayer
    Daniel Levine
    Chris Parker
    David Dearnaley
    Wim J. G. Oyen
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 901 - 907
  • [32] Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy
    Bashir, Usman
    Tree, Alison
    Mayer, Erik
    Levine, Daniel
    Parker, Chris
    Dearnaley, David
    Oyen, Wim J. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (04) : 901 - 907
  • [33] 68GA-PSMA-11 PET/CT VS 18F-FLUCICLOVINE PET/CT: A CASE SERIES IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL RECURRENCE
    Elkhoury, Fuad
    Calais, Jeremie
    Czernin, Johannes
    Fendler, Wolfgang
    Herrmann, Ken
    Eiber, Matthias
    Ceci, Francesco
    Reiter, Robert
    Marks, Leonard
    JOURNAL OF UROLOGY, 2018, 199 (04): : E259 - E259
  • [34] Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
    Calais, Jeremie
    Czernin, Johannes
    Fendler, Wolfgang P.
    Elashoff, David
    Nickols, Nicholas Nicholas G.
    BMC CANCER, 2019, 19 (1)
  • [35] Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
    Jeremie Calais
    Johannes Czernin
    Wolfgang P. Fendler
    David Elashoff
    Nicholas G. Nickols
    BMC Cancer, 19
  • [36] MAPPING OF SITE-SPECIFIC RELAPSE IN PATIENTS WITH BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY ASSESSED BY 68GA-PSMA-11 OR 11C-CHOLINE PET/CT: IMPACT OF POSTOPERATIVE ANDROGEN DEPRIVATION THERAPY AND RADIOTHERAPY
    Devos, Gaetan
    Witters, Manuel
    Everaerts, Wouter
    Raskin, Yannic
    Tosco, Lorenzo
    De Meerleer, Gert
    Goffin, Karolien
    Joniau, Steven
    JOURNAL OF UROLOGY, 2019, 201 (04): : E307 - E308
  • [37] 68Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer
    Sachpekidis, C.
    Eder, M.
    Kopka, K.
    Mier, W.
    Hadaschik, B. A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (07) : 1288 - 1299
  • [38] Randomized prospective phase 3 trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT].
    Calais, Jeremie
    Czernin, Johannes
    Fendler, Wolfgang P.
    Elashoff, David
    Nickols, Nicholas George
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] 68Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer
    C. Sachpekidis
    M. Eder
    K. Kopka
    W. Mier
    B. A. Hadaschik
    U. Haberkorn
    A. Dimitrakopoulou-Strauss
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1288 - 1299
  • [40] Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
    Calais, Jeremie
    Kishan, Amar U.
    Cao, Minsong
    Fendler, Wolfgang P.
    Eiber, Matthias
    Herrmann, Ken
    Ceci, Francesco
    Reiter, Robert E.
    Rettig, Matthew B.
    Hegde, John V.
    Shaverdian, Narek
    King, Chris R.
    Steinberg, Michael L.
    Czernin, Johannes
    Nickols, Nicholas G.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (11) : 1714 - 1721